Numbing Spray for Paracervical Pain
(VAPOR Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to assess if Num vapocoolant spray decreases pain associated with paracervical block in gynecology procedures.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you require narcotics, anxiolytics, or certain types of anesthesia for the procedure, you may not be eligible to participate.
What data supports the effectiveness of the treatment Num Vapocoolant Spray for paracervical pain?
Is the numbing spray safe for use in humans?
How does the numbing spray treatment for paracervical pain differ from other treatments?
Research Team
Mary Tschann, PhD
Principal Investigator
University of Hawaii
Eligibility Criteria
This trial is for individuals experiencing pelvic or paracervical pain during gynecological procedures. Specific eligibility criteria are not provided, so it's best to contact the study organizers for detailed requirements.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Num vapocoolant spray or placebo during their gynecologic procedure just before the paracervical block
Follow-up
Participants are monitored for pain and satisfaction immediately after the procedure
Treatment Details
Interventions
- Num Vapocoolant Spray
Find a Clinic Near You
Who Is Running the Clinical Trial?
Queen's Medical Center
Lead Sponsor
Lakshmi Devi and Devraj Sharma Endowment
Collaborator